Wipfli Financial Advisors’s Boston Scientific BSX Stock Holding History

Wipfli Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$519K	Buy	+13,393	New	+$537K	0.04%	217

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Wipfli Financial Advisors's BSX Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Boston Scientific (BSX) in Q3 2022: 13,393 shares worth $519K. The stake represents 0.04% of the portfolio and ranks #217 among its holdings.

864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Wipfli Financial Advisors held 13,393 shares of Boston Scientific worth $519K as of Q3 2022.
Boston Scientific was a new Wipfli Financial Advisors position in Q3 2022.
Boston Scientific made up 0.04% of Wipfli Financial Advisors's portfolio in Q3 2022, its #217 holding.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.